#Japan #Tokyo #Gut Health #BIO BALANCE #Abe Yōandon

Abe Yōandon Pharmaceutical Set to Launch 'BIO BALANCE Chōyū'

In response to the rapidly growing interest in longevity, particularly in Western countries, Abe Yōandon Pharmaceutical has announced the launch of its new gut health supplement, 'BIO BALANCE Chōyū'. This innovative product is scheduled for release in July 2026, reflecting the company’s commitment to promoting health and longevity.

Background of Development

Research over recent years highlights the vital role of gut microbiota in overall health, indicating that the balance of gut bacteria directly influences our wellbeing. As we age, beneficial bacteria, such as Bifidobacterium, tend to decline, leading to an imbalance in gut flora. This situation has driven Abe Yōandon Pharmaceutical to place a strong emphasis on gut care as a key area of focus in longevity science. Since its establishment in 1731, the company has been dedicated to advancing the health and wellbeing of individuals, marking gut health as a fundamental component of longevity.

Unique Formulation Features

The formulation of 'BIO BALANCE Chōyū' employs a tripartite design consisting of probiotics, prebiotics, and postbiotics, integrated with traditional Japanese herbal ingredients. Inspired by the concept of a 'bacterial relay,' where beneficial bacteria work in concert, the formulation has been meticulously developed to ensure the optimal combination and balance of its ingredients.

In detail, the probiotics include 3 billion Bifidobacterium longum and 1 billion spore-forming lactic acid bacteria per daily serving. The prebiotics consist of 1,000mg of lactulose and 300mg of fructooligosaccharides, while postbiotics include 50mg of lactic acid bacteria production substances. Additionally, the formula includes powdered cinnamon, a valuable ingredient traditionally utilized in herbal medicine.

Product Overview

• - Product Name: BIO BALANCE Chōyū
• - Contents: 2g x 30 single-serving sticks
• - Price: 12,960 JPY (including tax)
• - Release Date: July 2026
• - URL: Official Product Page
• - Key Ingredients: Bifidobacterium longum, spore-forming lactic acid bacteria, lactulose, fructooligosaccharides, lactic acid bacteria production substances, lactoferrin, powdered cinnamon
• - Allergens: Dairy products, soy (as per 29 specific allergens)

About Abe Yōandon Pharmaceutical

Since its founding in 1731, Abe Yōandon Pharmaceutical has been at the forefront of integrating Eastern medicinal wisdom with Western scientific understanding, focusing on achieving health and longevity. Through nearly 300 years of inheritance of health philosophies and cutting-edge longevity science, the company continues its unique research and development.

Company Information

• - Headquarters/Showroom: 1-5-4 Yanagihara, Adachi-ku, Tokyo, 120-0022, YAK Kitasenju Building
• - Ginza Office: 6-3-12 Sukiya Building, Ginza, Chūō-ku, Tokyo, 104-0061
• - Establishment: December 1984
• - CEO: Tomotaka Abe
• - Website: Abe Yōandon Corporate Site

For inquiries regarding this press release, please contact the Public Relations Department of Abe Yōandon Pharmaceutical at [email protected].